Company Seeks FDA Approval For Single-Dose Drug To Cure HIV/AIDS (nbc4i.com) 92
"Wednesday night was an exciting one for investors and employees at American Gene Technologies," reports a local Maryland news station. "After years in the making, they submitted a nearly 1,000-page document to FDA. And within its pages just may lie the cure for HIV/AIDS."
Founded in 2007, the privately-held company has less than 50 employees according to LinkedIn. Based in Maryland, the company's milestone was soon picked up by other local newscasts, including one attributed to WDVM/CNN.
Long-time Slashdot reader Aristos Mazer writes: This is not one of those on-going maintenance drugs. This, they claim in 1000+ pages of FDA filing, is an out-right cure. The drug, AGT 103T, delivers a virus that performs cell and gene therapy.
In AGT's words: "Gene therapy is a technique that allows doctors to treat a disorder by inserting genes into patients' cells to mitigate the underlying genetic drivers of disease. Human cells can be re-engineered to create highly-effective hunter/killers of invasive pathogens or cancer cells, or reprogramed to produce secretions that provide potent remedies to other disease conditions."
If FDA approves, then AGT will have the green light to begin phase one clinical trials in January 2020.
"Our aim is to treat HIV disease with an innovative cell and gene therapy that reconstitutes immunity to HIV and will control virus growth in the absence of antiretroviral drugs," the company's chief science officer told CBS Baltimore.
Founded in 2007, the privately-held company has less than 50 employees according to LinkedIn. Based in Maryland, the company's milestone was soon picked up by other local newscasts, including one attributed to WDVM/CNN.
Long-time Slashdot reader Aristos Mazer writes: This is not one of those on-going maintenance drugs. This, they claim in 1000+ pages of FDA filing, is an out-right cure. The drug, AGT 103T, delivers a virus that performs cell and gene therapy.
In AGT's words: "Gene therapy is a technique that allows doctors to treat a disorder by inserting genes into patients' cells to mitigate the underlying genetic drivers of disease. Human cells can be re-engineered to create highly-effective hunter/killers of invasive pathogens or cancer cells, or reprogramed to produce secretions that provide potent remedies to other disease conditions."
If FDA approves, then AGT will have the green light to begin phase one clinical trials in January 2020.
"Our aim is to treat HIV disease with an innovative cell and gene therapy that reconstitutes immunity to HIV and will control virus growth in the absence of antiretroviral drugs," the company's chief science officer told CBS Baltimore.
Sounds promising (Score:1)
Question (Score:3)
Re: Zombies - patient zero (Score:3, Funny)
Re: Zombies - patient zero (Score:4, Funny)
'They started a world wide fast zombie infestation which wiped out the human race in a matter of weeks. But at least they cured HIV." You mean like that?
You know what they say, "Don't let the perfect be the enemy of the good."
Re: (Score:1)
Re: (Score:2)
It does sound very interesting.
I'm betting this "single dose" is going to be very, very expensive.
Re: (Score:2)
I'm betting this single dose doesn't work. I can't see how, from the description given, something like this is supposed to work outside of a science fiction movie. In which it almost immediately goes rogue and produces a plague of zombies.
I doubt we'll hear much more about this once the media hype dies down.
Re: (Score:2)
I don't think making it work is the problem. It's fairly easy to create a virus that will splice a gene into a cell. T-cells are created all the time.
The problem is likely getting it to stop.
Re: (Score:1)
A "single dose" is often enough to infect you with any other virus, so that part seems fairly normal. Creating genetically engineered viruses sounds futuristic (it's only been 47 years since the first one!) but this is how gene therapy works and using it to treat HIV isn't a new idea. This is just the first company to potentially start human trials. We won't know the efficacy until after the trials, but it's not obvious why this would be uniquely riskier than any other GT treatment.
The GP guessed right that
Re: (Score:2)
Such a thorough and technical rebuttal is refreshing to see here on /. !!
Re: (Score:2)
Yep. I would guess at least $100,000 USD per dose in the first year, but maybe closer to a million. Hopefully the price will come down over time as more and more rich people get cured. I bet the investors were promised a starting price of a million per dose.
Re: (Score:1)
One part why not, One part limited infectiousness (Score:1)
Presumably, they'd use a virus that has a very limited lifespan.
That said, they're probably using a retrovirus much like HIV, but less lethal/more limited. One of its functions, which believe it or not, OTHER diseases have been known to do, is to disable HIV infected cells.
So I'd say that they'd prevent infection spread by having them practice safe sex and safe needle use for the infectious period, because it'd have a similar infection profile to HIV, IE STD and intravenous drug use.
That said, anybody mana
Re: (Score:2)
Lifespan is mostly not a relevant concept to viruses - which have no metabolic processes, and die in the act of infecting a cell.
You'd have to reliably keep the virus from successfully replicating once it infects a host cell in order to keep it from spreading - and doing that would likely make producing enough virii to do any good an extremely expensive proposition.
Re: (Score:2)
It will be expensive (Score:2)
If just one shot is needed then they will need to charge a lot of $$ to pay for all the R & D and to get a decent profit. But if just one shot is needed then most people (or insurance) will be happy to pay a lot to avoid having to take many doses of other drugs.
I hope that the existence of this does not mean that people will stop taking other precautions when having sex.
Re: (Score:2)
If just one shot is needed then they will need to charge a lot of $$ to pay for all the R & D and to get a decent profit.
Don’t worry, they’ve already set up a Patreon page.
Re: (Score:1)
All gene therapies are heinously expensive right now, in the hundreds of thousands of dollars. Maybe if something like this pans out, there will be an actual industry mass-producing the treatment and that will lower the costs.
Antibiotic resistant chlamydia, gonorrhea, etc. (Score:2)
Yeah, I second your hope that people don't stop taking other precautions when having sex. Other STDs have become incurable again too, or are incurable to begin with.
Antibiotics no longer work on some cases of gonorrhea and chlamydia, I'm not sure about syphilis. I hear that herpes isn't fun either, and the viruses that cause genital warts can also lead to cancer.
The world will change (Score:1)
Re: (Score:3)
I don't know about that. There are still plenty of STDs to go around, and many of them actually have worse symptoms than HIV (certainly when HIV is dormant and does not become full blown AIDs, which can be decades if taking the existing medications that are quite effective).
Re: The world will change (Score:1)
Re: The world will change (Score:1)
Reasons, such as availability, affordability, and education that the treatment actually exists.
Re: (Score:2)
Not only, but also reasons such as politicians flat out denying AIDS exists [wikipedia.org].
Re: (Score:2)
Well it is hard to afford a $3/day drug when your income is only $5 per day. Also they know that all they have to do is have sex with a young girl who is still a virgin and they will be completely cured.
Re: (Score:2)
nearly half of his paycheck is garnished for his offspring. “I don’t know what’s more surprising: that five sued or that 17 didn’t,” Nagel says.
Re: The world will change (Score:1)
Re: (Score:3)
Has already changed in the gay community.
PrEP is a highly effective way to prevent infection with HIV. It it quite hard on your liver however and so patients using it must have a 90 day checkup with their doctor to get a new prescription, where blood tests are done to check liver function, as well as a full STD screen.
Obviously not everyone is using PrEP nor can access it, but a very large number of people can.
I've seen some references to the fact that STD rates in general have declined thanks to PrEP, beca
Re: (Score:1)
Once they developed the very successful treatment to cure Hepatitis-C, I figured this would happen sooner rather than later. It's not the same approach, but once the retro-viruses start to fall, I think they'll all fall.
Even the "sticky" genotypes of HCV can now be cured easily (if not cheaply).
By the way, if you're between 30 and 60, you should definitely be tested for HC
Re: (Score:2)
There was only one sticky genotype of HCV, Genotype 1. Labeled 1 because it was the primary genotype discovered in white Americans when doctors and labs started separating HCV apart from the generic category of "non-A, non-B viral hepatitis". Genotypes 2-4 actually responded really well to Interferon treatments, I recall G4 having around a 50% cure rate after just 3 months back in the late 90s or early 2000s, when even simple antivirals weren't around to augment it. But G1, whether the TC or CT variant, had
Re: (Score:2)
Casual sex, condom use, etc. We may not go back all the way to "free love" of the 60s/70s, but there'll be a change.
This would be the biggest nightmare scenario for today's academic harpies. Nobody would read their articles on Slate any more.
Re: (Score:1)
Curing HIV is just a bonus (Score:2)
Did I just read that this thing can cure cancer?
Re: Curing HIV is just a bonus (Score:1)
Re: (Score:2)
Re: (Score:2)
You've got that a little backwards - *everyone* has cells becoming cancerous all the time, but normally your immune system kills such rogue cells quite effectively.
Occasionally though one of the mutant rogue cells will be "camouflaged" as a healthy cell and be able to multiply in peace - at which point you must resort to other methods to eliminate the entire population of cells. Leave even one single cell behind, and you're right back where you started. And tumors aren't structurally sound growths - it's
Re: Curing HIV is just a bonus (Score:1)
Re: Curing HIV is just a bonus (Score:1)
So, you googled cancer, and now you're an expert that we should defer to? Is that what you just said?
Re: Curing HIV is just a bonus (Score:1)
Re: (Score:2)
>There are a small number of people with cancer who are cancer free 10+ years later but this is not the expectation for most cancers.
Of course not - what part of the implication of "it will grow back if you leave even one single cancer cell alive" and "cancer cells break off of tumors and lodge themselves elsewhere in the body" isn't clear? Combine that with the fact that cancerous cells can look just like non-cancerous cells during surgery, and that none of the technologies that improve visibility are
Re: Curing HIV is just a bonus (Score:2)
The cause of most cancers is known â" it is mutation caused by viral or environmental factors. You cannot eliminate cancer, but it can be cured. Our cells mutate all the time because they are constantly bombarded with ionizing radiation and free radicals. Usually the mutation is corrected or not a big deal. If the mutation is bad, most of the time the cell commits suicide. If that doesnâ(TM)t happen, the immune system destroys the cancer cell. Only a mutant cell that got lucky enough to escape th
Re: Curing HIV is just a bonus (Score:1)
Re: Curing HIV is just a bonus (Score:1)
You know, you might not be the only person to research cancer due to a family member being diagnosed with it.
Can't wait.. (Score:5, Insightful)
Re: (Score:2)
In fifteen years, the price tag will drop to near nothing. Already, Gilead's pricing model is collapsing. Greed will also form copycats.
But then, the same techniques might also be rife for abuse, misuse, and creations of uber-humans. Imagine: no chance of malaria, cancer, HIV, HSV1/2, hepatitis anything, c.diff, cystic fibrosis, cholera, etc etc.
Only of course, if you can pay for it.
Re:Can't wait.. (Score:5, Insightful)
In fifteen years, the price tag will drop to near nothing.
And if not, the price will drop to a plane ticket to China plus a few bucks.
Seriously, if it's a one-time, one shot cure, you just fly to any country in the world that doesn't respect that US patent and get your shot, then come home. I bet at least a few European countries will go that way. If you've got socialized health care, it's crazy not to. The monetary benefit would be tremendous.
A whole lot of the things you mention cost orders of magnitudes more to deal with over a lifetime than a plane ticket. Or a bus ride to Canada. Or a cruise that stops in Havana.
Re: (Score:2)
Maybe a trip to Mumbai isn't so bad....
Re: (Score:2)
Seriously, if it's a one-time, one shot cure, you just fly to any country in the world that doesn't respect that US patent and get your shot, then come home. I bet at least a few European countries will go that way.
Well, no. If you do that you'll have the WTO up your ass in a heartbeat.
Re: (Score:2)
>And if not, the price will drop to a plane ticket to China plus a few bucks.
I worked out that this is also true for getting a nice custom suit made. However I'll wait for my next business trip there and save myself the personal airfare.
Re: (Score:2)
Paying for it (Score:1)
Remember that most countries have some form of universal health coverage. In addition, infectious diseases is one of those areas where it's better to not catch the disease at all, even if you can purchase a cure for it. The cure may not work on you, for example, or have bad side effects.
So it actually makes sense for smart rich people(I know, many are NOT smart) to pay to have all the lower wealth people cured, because that provides protection for them. Sure, it is a relatively expensive way to do it, bu
Re: (Score:2)
This is unlikely to happen. Worse, I fear for its potential abuse. Despite that fear, I'm hoping it works in trials.
Re: (Score:2)
Re: (Score:1)
Re: (Score:2)
Pharmaceutical corporations make zero decisions based on what is good or right for humanity. Zero. Not a single one. The good of humanity has a weight of exactly zero when they make decisions. I have seen them admit this openly. They will do whatever they think will bring in the most profits. They feel no shame in admitting this and it is their sole purpose.
Whether they would go full Michael Clayton and simply have the key people behind this threat killed is another matter because that means breaking the la
Be hopeful, but don't hold your breath (Score:4)
The number of drugs that make it from Phase I Clinical studies to market is a percent or two. Safety issues that don't show up in petri dish or animal experiments can easily derail such products.
And this is a novel drug, it will get a lot of scrutiny... But it's a major advance, it will get prompt, likely fast-track review.
Re: (Score:1)
And this is a novel drug, it will get a lot of scrutiny... But it's a major advance, it will get prompt, likely fast-track review.
A bunch of desperate rich folks who have HIV/AIDS are probably inquiring how to get this drug now on the black market.
Even without any review or further tests.
Re:Be hopeful, but don't hold your breath (Score:5, Insightful)
Doubtful, because HIV is no longer a death sentence and hasn't really been since the late 90s. Life expectancy of someone with HIV is very close to that of someone of the same demographics without it. Since the 90s the side-effects of the drugs have gotten much better and aren't much of a big deal now.
Rich people can obviously afford these drugs. No reason to risk their lives or potentially suffer serious complications from an untested drug like this.
Re: (Score:1)
Re: (Score:3)
However, it's still a hit to their ego and a hit to their ability to get sexual partners on a whim.
Those are still powerful motivators to people with more money than sense.
Re: (Score:2, Insightful)
Unless you are female and young and superhot I think you can forget about any sexual partners for the rest of your life. Unless you are willing to lie about your HIV+ status which is a crime in some countries. You may even have trouble keeping friends once they found out. Best thing would be to pal up with a non-human animal like a dog or parrot because no human will ever want to be with you again. That part of your life is over when you get HIV.
Re: (Score:3)
You know how people refer to their being stigma against HIV?
That's what your comment is.
Re:Be hopeful, but don't hold your breath (Score:4, Informative)
The number of drugs that make it from Phase I Clinical studies to market is a percent or two.
No, that's from initial research, also sometimes confusingly called phase one. Most ideas die on the drawing board or in lab/animal testing. If you've reached clinical trials it's about 1 in 10, but that's just an average spread across many types of medications from incremental improvements to niche treatments for rare conditions and any radically new class of drug probably has much lower probability than that.
Re: (Score:3)
Phase I to market is about 20%. But that includes a lot of drug tweaks, iterations, and other stuff that's pretty much guaranteed to succeed. The success rates of new class drugs, and particularly "drugs" that are actually viruses doing in vivo genetic therapy, are a lot lower.
Phase 1 (Score:5, Insightful)
If FDA approves, then AGT will have the green light to begin phase one clinical trials in January 2020.
It's phase 1, that means they are still trying to determine whether it will kill people or not. Not really worth getting your hopes up.
tempered expectations, but the right thing to do (Score:4, Interesting)
As many people have pointed out, this is a phase 1 trial, meaning that it's (statistically) very unlikely to pan out right away.
For the last few decades, it's become obvious that large pharma companies are unable to pursue drugs like this effectively. The scientific, regulatory, and ethical risks here are very high. The company pursuing this is a "pharma startup", a company financially designed to take these risks. They've been working on this commercially for 12 years (after earlier academic work). Even so, the cost for them to do this is much less than what a large company would have paid.
These kinds of high-risk high-reward projects are necessary and much more common in tech than in pharma. It's easy to see why. It took them 12 years to get far enough to file their application to start clinical trials (they're almost as old as Facebook). Good for these guys for getting this far and shooting for a real world improving success.
Phase 1 trials are not newsworthy (Score:2)
Until a drug like this gets to Phase 3 it's simply not newsworthy. Phase 1 is where so many drugs get cut since it's usually a very low dose first wave human trial.
The headline makes it sound like they're about to file which is very misleading.
Re: (Score:2)
Phase 1 trials for HIV or cancer *cures*, especially ones involving novel new technology, are newsworthy.
But not in a "this is about to cure the disease" sort of angle that this is being slanted with.
Re: (Score:2)
After which, FDA market approval can be requested. (source) [centerwatch.com]
God won't be happy. (Score:1)
Re: (Score:1)
Re: (Score:2)
Captain Trips. LOL. Perhaps this is Captain Trips. Or that virus in Jeremiah, whatever it was called (I forget).
Re: (Score:2)
So it's not actually a drug is it? (Score:2)
I hope it works (Score:2)
I am skeptical about the one shot part. But even if the cells persist a year or two in my opinion thats a win. The other thing I am skeptical about is whether it (alone) can cause the CD4 T-cell count to increase in patients whose CD4 cells have depleted.
Do they deserve billionds of dollars? (Score:1)
Do the inventors, the inventors and others at this company (or any other, that will deliver the cure) deserve billions of dollars in financial rewards?
Or are we going to demand, they make it affordable, stopping profiteering on the backs of the innocent sufferers, and sell it at the same price, at which one can get it in Botswana?
Biohackers and CRISPR CAS9 will beat them anyway (Score:2)
Hiv cure (Score:1)